ÂÜÀòÂÒÂ×

Patti Doherty is a seasoned professional in the fields of life science and technology, currently serving as Principal at Popper and Company since February 2007, where responsibilities include corporate strategy development, commercialization, and regulatory strategy implementation. Prior experience includes serving as Director of Clinical Studies at Exagen Diagnostics from March 2004 to December 2007, where collaboration with computational and molecular biology staff facilitated the writing of clinical research protocols and study design. Patti also coordinated HIV research surveys for the Centers for Disease Control and Prevention through a role at the New Mexico Department of Health Epidemiology from 1989 to 1999, focusing on surveys for high-risk populations. Educational qualifications include a degree in Liberal Arts from The University of New Mexico and a nursing degree from the University of Albuquerque.